TY  - JOUR
AU  - Collazos, Julio
AU  - Domingo, Pere
AU  - Fernandez-Araujo, Nerio
AU  - Asensi-Diaz, Elia
AU  - Vilchez-Rueda, Helem
AU  - Lalueza, Antonio
AU  - Roy-Vallejo, Emilia
AU  - Blanes, Rosa
AU  - Raya-Cruz, Manuel
AU  - Sanz-Canovas, Jaime
AU  - Artero, Arturo
AU  - Ramos-Rincon, Jose-Manuel
AU  - Dueñas-Gutierrez, Carlos
AU  - Lamas-Ferreiro, Jose Luis
AU  - Asensi, Victor
PY  - 2022
DO  - 10.1371/journal.pone.0262777
UR  - http://hdl.handle.net/10668/20415
T2  - PloS one
AB  - Valproic acid (VPA) has shown beneficial effects in vitro against SARS-CoV-2 infection, but no study has analyzed its efficacy in the clinical setting. This multicenter, retrospective study included 165 adult patients receiving VPA at the time of...
LA  - en
PB  - Public Library of Science
KW  - Severity of Illness Index
KW  - Spain
KW  - Treatment Outcome
KW  - Valproic Acid
KW  - COVID-19 Drug Treatment
KW  - Aged
KW  - Blood Cell Count
KW  - COVID-19
KW  - Female
KW  - Hospitalization
KW  - Humans
KW  - Inflammation
KW  - Lung
KW  - Male
KW  - Middle Aged
KW  - Retrospective Studies
KW  - SARS-CoV-2
TI  - Exposure to valproic acid is associated with less pulmonary infiltrates and improvements in diverse clinical outcomes and laboratory parameters in patients hospitalized with COVID-19.
TY  - research article
VL  - 17
ER  -